Replacing the tricuspid valve to treat severe leakage
Part of Heart & circulation clinical trials.
This trial tests a new device called the Laplace system, which replaces the tricuspid valve in your heart without open-heart surgery. It is designed for people with severe tricuspid regurgitation (a leaky heart valve) who still have symptoms despite taking medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 90 years old.
- You have symptoms like shortness of breath or fatigue, even after taking heart medications for at least a month.
- Your tricuspid valve leak is graded as severe, massive, or torrential.
- Your heart team agrees that this procedure is a good option for you.
- You do not have severe kidney disease, a recent stroke, or a life expectancy under 12 months.
- You are willing to come back for all follow-up visits after the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device that replaces a leaky tricuspid valve (a heart valve) without open-heart surgery. If your tricuspid valve isn't working well and medicines haven't helped enough, this procedure might improve your heart function and symptoms.
This study tests a new device to fix a leaky tricuspid valve without open-heart surgery. It is for people with severe leakage who are considered too high-risk for traditional surgery.
This trial tests a catheter-based procedure (done through the blood vessels) to repair a severely leaky tricuspid valve. It may help people with symptoms or past hospitalizations from tricuspid valve leakage who are higher-risk for standard surgery.
This trial tests a new device called TricValve, which is placed through a catheter (a thin tube) to fix a leaky tricuspid valve on the right side of the heart. It aims to reduce blood flowing backward and improve heart failure symptoms for people who can't have open-heart surgery and haven't been helped by other catheter treatments.
This study tests a new device to help people with severe tricuspid regurgitation (leaky heart valve) who are at higher risk from surgery. It aims to see if the device can reduce the leak and improve symptoms.
This trial studies a catheter-based procedure to replace the tricuspid valve in people with severe valve leakage. It aims to improve symptoms and heart function while tracking safety and effectiveness.
Hear when a new Severe Tricuspid Valve Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.